BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 27225754)

  • 1. Brain metastases as site of first and isolated recurrence of breast cancer: the role of systemic therapy after local treatment.
    Niwińska A
    Clin Exp Metastasis; 2016 Oct; 33(7):677-85. PubMed ID: 27225754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors affecting the prognosis of breast cancer patients with brain metastases.
    Saip P; Cicin I; Eralp Y; Kucucuk S; Tuzlali S; Karagol H; Aslay I; Topuz E
    Breast; 2008 Oct; 17(5):451-8. PubMed ID: 18455400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary breast cancer phenotypes associated with propensity for central nervous system metastases.
    Tham YL; Sexton K; Kramer R; Hilsenbeck S; Elledge R
    Cancer; 2006 Aug; 107(4):696-704. PubMed ID: 16826579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain metastases in breast cancer: prognostic factors and management.
    Lee SS; Ahn JH; Kim MK; Sym SJ; Gong G; Ahn SD; Kim SB; Kim WK
    Breast Cancer Res Treat; 2008 Oct; 111(3):523-30. PubMed ID: 17990100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical predictors of long-term survival in HER2-positive metastatic breast cancer.
    Murthy P; Kidwell KM; Schott AF; Merajver SD; Griggs JJ; Smerage JD; Van Poznak CH; Wicha MS; Hayes DF; Henry NL
    Breast Cancer Res Treat; 2016 Feb; 155(3):589-95. PubMed ID: 26875184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond breast specific-Graded Prognostic Assessment in patients with brain metastases from breast cancer: treatment impact on outcome.
    Griguolo G; Dieci MV; Giarratano T; Giorgi CA; Orvieto E; Ghiotto C; Berti F; Della Puppa A; Falci C; Mioranza E; Tasca G; Milite N; Miglietta F; Scienza R; Conte P; Guarneri V
    J Neurooncol; 2017 Jan; 131(2):369-376. PubMed ID: 27853958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gamma knife surgery for the treatment of intracranial metastases from breast cancer.
    Goyal S; Prasad D; Harrell F; Matsumoto J; Rich T; Steiner L
    J Neurosurg; 2005 Aug; 103(2):218-23. PubMed ID: 16175849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer subtypes and response to systemic treatment after whole-brain radiotherapy in patients with brain metastases.
    Niwińska A; Murawska M; Pogoda K
    Cancer; 2010 Sep; 116(18):4238-47. PubMed ID: 20549816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gamma Knife surgery for metastatic brain tumors from primary breast cancer: treatment indication based on number of tumors and breast cancer phenotype.
    Matsunaga S; Shuto T; Kawahara N; Suenaga J; Inomori S; Fujino H
    J Neurosurg; 2010 Dec; 113 Suppl():65-72. PubMed ID: 21121788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival of breast cancer patients with synchronous or metachronous central nervous system metastases.
    Ho VK; Gijtenbeek JM; Brandsma D; Beerepoot LV; Sonke GS; van der Heiden-van der Loo M
    Eur J Cancer; 2015 Nov; 51(17):2508-16. PubMed ID: 26277099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival among patients with 10 or more brain metastases treated with stereotactic radiosurgery.
    Rava P; Leonard K; Sioshansi S; Curran B; Wazer DE; Cosgrove GR; Norén G; Hepel JT
    J Neurosurg; 2013 Aug; 119(2):457-62. PubMed ID: 23662828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control.
    Iorio-Morin C; Masson-Côté L; Ezahr Y; Blanchard J; Ebacher A; Mathieu D
    J Neurosurg; 2014 Dec; 121 Suppl():69-74. PubMed ID: 25434939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reoperation for recurrent metastatic brain tumors.
    Bindal RK; Sawaya R; Leavens ME; Hess KR; Taylor SH
    J Neurosurg; 1995 Oct; 83(4):600-4. PubMed ID: 7674007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensified local treatment and systemic therapy significantly increase survival in patients with brain metastases from advanced breast cancer - a retrospective analysis.
    Bartsch R; Fromm S; Rudas M; Wenzel C; Harbauer S; Roessler K; Kitz K; Steger GG; Weitmann HD; Poetter R; Zielinski CC; Dieckmann K
    Radiother Oncol; 2006 Sep; 80(3):313-7. PubMed ID: 16959347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic radiosurgery as primary and salvage treatment for brain metastases from breast cancer. Clinical article.
    Kondziolka D; Kano H; Harrison GL; Yang HC; Liew DN; Niranjan A; Brufsky AM; Flickinger JC; Lunsford LD
    J Neurosurg; 2011 Mar; 114(3):792-800. PubMed ID: 20887087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
    Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salvage stereotactic radiosurgery for breast cancer brain metastases: outcomes and prognostic factors.
    Kelly PJ; Lin NU; Claus EB; Quant EC; Weiss SE; Alexander BM
    Cancer; 2012 Apr; 118(8):2014-20. PubMed ID: 21918959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic significance of surgically treated hydrocephalus in leptomeningeal metastases.
    Jung TY; Chung WK; Oh IJ
    Clin Neurol Neurosurg; 2014 Apr; 119():80-3. PubMed ID: 24635931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolated local recurrence or solitary solid organ metastasis after esophagectomy for cancer is not the end of the road.
    Depypere L; Lerut T; Moons J; Coosemans W; Decker G; Van Veer H; De Leyn P; Nafteux P
    Dis Esophagus; 2017 Jan; 30(1):1-8. PubMed ID: 27704661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors affecting the outcome of brain metastases from breast cancer.
    Liu MT; Hsieh CY; Wang AY; Chang TH; Pi CP; Huang CC; Huang CY; Liou CH
    Support Care Cancer; 2006 Sep; 14(9):936-42. PubMed ID: 16575571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.